Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration


Autoria(s): Wallis, Steven C.; Mullany, Dan V.; Lipman, Jeffrey; Rickard, Claire M.; Daley, Peter J.
Contribuinte(s)

K. J. Falke

Data(s)

01/04/2001

Resumo

Objectives: To investigate the pharmacokinetics of intravenous ciprofloxacin 200 mg every 8 h in critically ill patients on continuous veno-venous haemodiafiltration (CVVHDF), one form of continuous renal replacement therapy (CRRT). Design and setting: Open, prospective clinical study in a multidisciplinary, intensive care unit in a university-affiliated tertiary referral hospital. Patients: Sis critically ill patients with acute renal failure on CVVHDF. Interventions: Timed blood and ultrafiltrate samples were collected to allow pharmacokinetics and clearances to be calculated of initial and subsequent doses of 200 mg intravenous ciprofloxacin. CVVHD was performed with 1 l/h of dialysate and 2 l/h of predilution filtration solution, producing 3 lih of dialysis effluent. The blood was pumped at 200 ml/min using a Gambro BMM-10 blood pump through a Hospal AN69HF haemofilter,. Measurements and results: Ten pharmacokinetic profiles were measured. The CVVHDF displayed a urea clearance of 42 +/- 3 ml/min, and removed ciprofloxacin with a clearance of 37 +/- 7 ml/min. This rate was 2-2.5 greater than previously published for ciprofloxacin in other forms of CRRT. On average the CVVHDF was responsible for clearing a fifth of all ciprofloxacin eliminated (21 +/- 10%). The total body clearance of ciprofloxacin was 12.2 +/- 4.3 l/h. The trough concentration following the initial dose was 0.7 +/- 0.3 mg/l. The area under the plasma concentration time curves over a 24-h period ranged from 21 to 55 mg .h l(-1). Conclusions: Intravenous ciprofloxacin 600 mg/day in critically ill patients using this form of CRRT produced adequate plasma levels for many resistant microbes found in intensive care units.

Identificador

http://espace.library.uq.edu.au/view/UQ:59656

Idioma(s)

eng

Publicador

Springer-Verlag

Palavras-Chave #Critical Care Medicine #Antibiotics #Ciprofloxacin #Pharmacokinetics #Continuous Renal Replacement Therapy #Sepsis #Renal Replacement Therapy #Critically Ill Patients #Intravenous Ciprofloxacin #Severe Sepsis #Hemofiltration #Hemodiafiltration #Pharmacodynamics #Hemodialysis #Disease #Serum #C1 #320500 Pharmacology and Pharmaceutical Sciences #730100 Clinical (Organs, Diseases and Abnormal Conditions) #110310 Intensive Care
Tipo

Journal Article